Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis
Lung cancer is among the major causes of cancer deaths, and the survival rate of lung cancer patients is extremely low. Recent studies have demonstrated that the gene CDKN3 is related to neoplasia, but in the literature severe controversy exists over whether it is involved in cancer progression or,...
Main Authors: | Xiao Zang, Min Chen, Yunyun Zhou, Guanghua Xiao, Yang Xie, Xinlei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-01-01
|
Series: | Cancer Informatics |
Online Access: | https://doi.org/10.4137/CIN.S17287 |
Similar Items
-
Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis
by: Xiao Zang, et al.
Published: (2015-05-01) -
Combining Genetic Mutation and Expression Profiles Identifies Novel Prognostic Biomarkers of Lung Adenocarcinoma
by: Yun Liu, et al.
Published: (2020-10-01) -
CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
by: Dayong Xiao, et al.
Published: (2020-10-01) -
Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
by: Sijin Sun, et al.
Published: (2021-03-01) -
DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma
by: Yang-Jie Wu, et al.
Published: (2021-09-01)